Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 48.40 +0.90 (+1.89%) As of 08/14/2025 12:01 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Beximco Pharmaceuticals Stock Price Performance The Beximco Pharmaceuticals (BXP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 40.29%, with a year-to-date return of 26.70%. In the past month, the stock has increased 21.46%, reflecting recent market activity. As of the latest close, Beximco Pharmaceuticals traded at GBX 48.40 with a market cap of £32.99 billion and volume of 57,688 shares. Five years ago, the stock traded at GBX 51, representing a 5.10% decrease over that period. At the time, it had a market cap of £206.83 million and a volume of 52,765 shares. Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.56%1 Month Performance+21.46%3 Month Performance+30.99%Year-To-Date Performance+26.70%1 Year Performance+40.29%5 Year Performance-5.10% BXP Stock Chart for Friday, August, 15, 2025 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025GBX 47GBX 48.40+2.98%GBX 48.89GBX 4657,688 shs£32.99 billion08/13/2025GBX 48.45GBX 47-2.99%GBX 48.45GBX 4726,539 shs£32.04 billion08/12/2025GBX 47GBX 48.45+3.09%GBX 48.45GBX 47.5011,225 shs£33.03 billion08/11/2025GBX 44.50GBX 47+5.62%GBX 48GBX 44.60151,732 shs£32.04 billion08/08/2025GBX 45GBX 45GBX 45GBX 43.5519,976 shs£30.68 billion08/07/2025GBX 45GBX 45GBX 45GBX 43.5519,976 shs£30.68 billion08/06/2025GBX 45GBX 45GBX 45GBX 42.3314,848 shs£30.68 billion08/05/2025GBX 40GBX 45+12.50%GBX 45GBX 38.89183,946 shs£30.68 billion08/04/2025GBX 39GBX 40+2.56%GBX 40GBX 39153,500 shs£27.27 billion08/01/2025GBX 39GBX 39GBX 41GBX 3919,598 shs£26.59 billion Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025GBX 39.89GBX 39-2.23%GBX 41GBX 3919,798 shs£26.59 billion07/30/2025GBX 41GBX 39.89-2.71%GBX 39.89GBX 395,616 shs£27.19 billion07/29/2025GBX 39.10GBX 41+4.86%GBX 41GBX 39.1033,469 shs£27.95 billion07/28/2025GBX 39.10GBX 39.10GBX 39.50GBX 39.105,064 shs£26.65 billion07/25/2025GBX 40.75GBX 39.10-4.05%GBX 39.50GBX 39.1051,315 shs£26.65 billion07/24/2025GBX 40.37GBX 40.75+0.95%GBX 40.75GBX 38.5092,597 shs£27.78 billion07/23/2025GBX 40.85GBX 40.37-1.18%GBX 41GBX 40.3343,188 shs£27.52 billion07/22/2025GBX 39.50GBX 40.85+3.41%GBX 40.85GBX 39.5014,886 shs£27.84 billion07/21/2025GBX 39.50GBX 39.50GBX 39.78GBX 39.5028,098 shs£26.93 billion07/18/2025GBX 39.77GBX 39.77GBX 39.78GBX 39.7738,098 shs£27.11 billion07/17/2025GBX 40GBX 39.77-0.57%GBX 39.78GBX 39.7738,098 shs£27.11 billion07/16/2025GBX 39.85GBX 40+0.38%GBX 40.74GBX 3943,992 shs£27.27 billion07/15/2025GBX 38.66GBX 39.85+3.08%GBX 39.85GBX 38.502,772 shs£27.16 billion07/14/2025GBX 39.98GBX 38.66-3.30%GBX 40GBX 38.668,113 shs£26.35 billion Related Companies Ashtead Group Stock Chart Land Securities Group Stock Chart Taylor Wimpey Stock Chart Safestore Stock Chart EVRAZ Stock Chart Molten Ventures Stock Chart Prs Reit Stock Chart Pinewood Technologies Group Stock Chart AdvancedAdvT Stock Chart Aurora Investment Trust Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.